m&a advisor

Conalliance is also known for well established independent business valuation.

Conalliance is renowned for conducting Commercial Due Diligence and rendering objective and credible valuation reports and opinions.

The close affiliation between Conalliance member companies provides our firm with the unmatched capability to understand the key valuation drivers within an organization, and to identify opportunities for shareholder value enhancement from transaction planning through to closing.

sale of company / transaction advisory

Assessment

In this initial phase, Conalliance assesses the market value of healthcare assets, the core drivers of value, the challenges and opportunities associated with operating the assets, and determines viable strategic alternatives available to the client.

Preparation

The firm develops a selling strategy for the health care assets, identifies potential purchasers or investors, prepares confidential marketing materials and assists in the selection of the client’s transaction advisory team (i.e., attorneys, accountants, wealth managers, etc.).

disposal medical device manufacturer

If you place certain medical devices on the EU market you or your authorised representative (agent) must be registered with the competent authority (national health regulator) in the EU state where you have an office or place of business. In the UK, Medicines and Healthcare Products Agency (MHRA) is the competent authority for the registration of medical devices. MHRA will only register manufacturers or authorised representatives that have a place of business in the UK. Medical devices are categorised by type (class) and your registration will include the type of device you sell. Before you register, you must first complete a conformity assessment , so you can put the CE marking on your products.

m&a pharmaceuticals, drugs, API

Conalliance has established a reputation for handling high profile pharmaceuticals, drugs, API merger and acquisition, and corporate strategic advisory engagements. The firm advances the best interests of its clients by understanding each client's needs and objectives, providing a clear valuation assessment of the pharmaceuticals, drugs, API assets, and maximizing the client's financial aspirations through effective planning, execution and anticipation of market trends. Conalliance places a premium on its relationship with clients and believes that the professionalism, commitment, knowledge, creativity and integrity of the people within its organization is essential to the long-term success of its clientele.

mergers & acquisitions: sale and acquisition advisors for midsize business